Innovax®-ND-ILT
Administered as a single in-ovo or subcutaneous injection, Innovax-ND-ILT provides effective 3-in-1 protection against Marek’s Disease (MD), Newcastle Disease (ND) and Infectious Laryngotracheitis (ILT).
Learn more about Innovax ND-ILT and its benefits below:
Convenient 3-IN-1 Protection
Innovax-ND-ILT provides protection against Newcastle Disease, Infectious Laryngotracheitis and Marek's Disease from a single in-ovo or subcutaneous injection, helping to reduce the number of vaccinations required on farm.
For more product information:
Excellent Safety Profile
In registration trials no adverse reactions were observed following in-ovo and subcutaneous vaccination at 10 x the field dose with no impact on hatchability or average weight gain.1
Have a question to ask?
Long Lasting Disease Prevention
Innovax-ND-ILT provides 62 week duration of immunity for Newcastle Disease and Infectious Laryngotracheitis, and the entire risk period for Marek's Disease.
For more information on Innovax-ND-ILT and it's indication for use:
No Reversion To Virulence
Innovax-ND-ILT contains only fragments of ILT and ND viruses, safety trials demonstrated no horizontal spread of vaccine virus or reversion to virulence.1
Have a question to ask?
Proven Performance
Challenge studies have demonstrated that Innovax-ND-ILT provides excellent protection against all three pathogens following single in-ovo or subcutaneous vaccination.1
For more information on Innovax-ND-ILT:
Innovax®-ND-ILT contains cell-associated live recombinant turkey herpesvirus (strain HVT/NDV/ILT), expressing the fusion protein of Newcastle disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus: 103.3 – 104.3 PFU. POM-V. Nobilis® Rismavac contains live cell associated Marek’s disease virus strain CVI988 ≥ 3.0 log10 TCID50. POM-VPS.
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
MSD Animal Health UK Limited, Walton Manor, Walton, Milton Keynes, MK7 7AJ, UK
Registered in England & Wales no. 946942
References
1. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek’s diseases. Gergen et al. Avian Pathology 2019, VOL. 48, NO. 1, 45-56.
